Discover top stock picks and new investment opportunities through TipRanks' Smart Investor Newsletter. Memphasys Ltd ( (AU:MEM)) just unveiled an announcement. Memphasys Limited has entered into a ...

Just because a business does not make any money, does not mean that the stock will go down. Indeed, Memphasys (ASX:MEM) stock is up 117% in the last year, providing strong gains for shareholders. But ...

With more than 600k average monthly users on the HotCopper forums, each and every discussion can move markets. That’s why ...

We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. On the other hand, we'd be remiss not to mention that insider sales have been known ...

Memphasys Ltd (ASX:MEM, OTC:MPHSF, FRA:IG7) has executed a 12-month exclusive national supply agreement with Monash IVF Group Ltd (ASX:MVF) (ASX) for the rollout of its Felix™ automated sperm ...

Just because a business does not make any money, does not mean that the stock will go down. For example, Memphasys (ASX:MEM) shareholders have done very well over the last year, with the share price ...

Memphasys Ltd is nearing the completion of its clinical trial for the Felix™ System, a groundbreaking sperm selection technology poised to revolutionize assisted reproductive treatments. With 95% of ...

Memphasys Limited has appointed Lindley Edwards as the new Non-Executive Chairperson, succeeding Robert Cooke, as the company nears the completion of its clinical trial for the Felix™ System. Edwards ...

Memphasys (ASX:MEM) has signed a three-year Thailand distribution deal with IVF Envimed for its Felix sperm separation system ...

Memphasys Ltd. Annual stock financials by MarketWatch. View the latest MEM financial statements, income statements and financial ratios.

Memphasys has successfully collected data from approximately 240 horse inseminations to test its novel “SAMSON” stallion fertility diagnostic device that may cut sperm diagnosis times down to a rapid ...

Reproductive biotechnology company Memphasys has received a boost for its flagship Felix system, with the first global study of its kind rating the novel technology as “best available” for recovering ...